Radiotherapy Market Upcoming Trend and Fast Forward Research 2025: Accuray, Elekta, Varian Medical Systems, CIVCO Medical Solutions, CR Bard, Brainlab, Isoray Medical, Inc., Nordion, RaySearch Laboratories, Hitachi, Mevion Medical Systems & More

The radiographers will then leave the room. They will have the capacity to see you and might have the capacity to address you through a radio. The treatment itself takes a couple of minutes and isn't agonizing.

New research report of Global radiotherapy market is predictable to reach USD 9.3 billion by 2024 from USD 5.2 billion in 2016, at a CAGR of 7.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Beam radiotherapy market has the largest market segment in radiotherapy market.

To request sample copy or view summary of this report, click the link below @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-radiotherapy-market

The global radiotherapy market is highly concentrated to a big player and rest to local players who cater to domestic markets only. Varian Medical Systems, Inc. dominated the radiotherapy market accounting for a highest market share in 2016. Other players in this market include Elekta AB, Accuray, Inc., CIVCO Medical Solutions, Brainlab AG, C. R. Bard, Inc., IsoRay Medical, Inc., Nordion, Inc., RaySearch Laboratories AB, PRECISIS AG, Mevion Medical Systems, Inc., Technicas Radiofiscas S.L., Hitachi, Ltd., Sumitomo Heavy Industries, Ltd., Mitsubishi Electric Corporation, ProNova Solutions, LLC, ProTom International.

Beam radiotherapy

Beam radiotherapy is a treatment that utilizations high-vitality pillars to crush disease cells. The shafts are given utilizing gear like an extensive x-beam machine. A radiographer works the machine.

This sort of radiotherapy might be utilized to:

• Treat and fix the disease (therapeudic or radical radiotherapy)

• Control side effects caused by the disease (palliative radiotherapy).

Before you have your radiotherapy, you might be solicited to remove some from your garments and wear an outfit. The radiographers will utilize any imprints on your skin (and on your cover, in the event that you have one) to enable you to get into the right position. They will ensure you are agreeable.
The radiographers will then leave the room.

They will have the capacity to see you and might have the capacity to address you through a radio. The treatment itself takes a couple of minutes and isn't agonizing.

It's ordinary to feel stressed over having outer radiotherapy. Yet, don't be reluctant to converse with the radiotherapy staff about your stresses – they are there to help.

Elekta AB:

Founded in 1972 and headquartered in Stockholm, Sweden by Lars Leksell and Laurent Leksell. Elekta is a provider of human care, which specialises in the treatment of cancers and brain disorders. It provides oncologists, radiation therapists, neurosurgeons, and other medical specialists with the aid of clinical solutions and tools.

Recent Developments:

1. In December 2016, Elekta, Stockholm's County Council and New Karolinska Solna (NKS) have signed a 13-year collaboration agreement which focuses on innovation, joint research and education and training within advanced radiation therapy.

2. In March 2016, Elekta announced the strategic partnership with Genesis care where, the later will acquire Elekta’s Leksell Gamma Knife Icon radiosurgery systems, Versa HD linear accelerators, brachytherapy systems, software as well as services. These products and solutions will be acquired by Genesis Care cancer treatment centres in Australia, the UK and new markets.

Have Any Query? Inquire here @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-radiotherapy-market

TABLE OF CONTENTS GLOBAL RADIOTHERAPY MARKET
1. INTRODUCTION

1.1. OVERVIEW OF GLOBAL RADIOTHERAPY MARKET
1.1.1. CURRENCY AND PRICING
1.1.2. LIMITATION
1.1.3. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS

3.1.1. GROWING PREVALENCE OF CANCER
3.1.2. RISING AGEING POPULATION
3.1.3. UNHEALTHY LIFESTYLE
3.1.4. MERGERS AND ACQUISITIONS TO EXPAND BUSINESS

3.2. RESTRAINTS

3.2.1. REGULATORY SCENARIO
3.2.2. HIGH COST OF RADIOTHERAPY

3.3. OPPORTUNITIES

3.3.1. GROWING MEDICAL TOURISM IN ASIA
3.3.2. EMERGING MARKET

3.4. CHALLENGES

3.4.1. SIDE-EFFECTS OF RADIOTHERAPY
3.4.2. REQUIREMENT OF TRAINED STAFF

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. GLOBAL RADIOTHERAPY MARKET, BY THERAPY TYPE

6.1. OVERVIEW
6.2. BEAM RADIOTHERAPY, BY THERAPY TYPE
6.3. BRACHYTHERAPY, BY THERAPY TYPE

7. GLOBAL RADIOTHERAPY MARKET, BY PRODUCT TYPE

7.1. OVERVIEW
7.2. GLOBAL EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT TYPE
7.3. GLOBAL INTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT TYPE
7.4. GLOBAL RADIOTHERAPY SOFTWARES MARKET, BY PRODUCT TYPE

8. GLOBAL RADIOTHERAPY MARKET, BY INDICATION

8.1. OVERVIEW

9. GLOBAL RADIOTHERAPY MARKET, BY GEOGRAPHY

9.1. OVERVIEW

9.2. NORTH AMERICA RADIOTHERAPY MARKET SNAPSHOT: 2016

9.2.1. U.S. RADIOTHERAPY MARKET
9.2.2. CANADA RADIOTHERAPY MARKET
9.2.3. MEXICO RADIOTHERAPY MARKET

9.3. EUROPE RADIOTHERAPY MARKET

9.3.1. GERMANY RADIOTHERAPY MARKET
9.3.2. FRANCE RADIOTHERAPY MARKET
9.3.3. U.K. RADIOTHERAPY MARKET
9.3.4. SWITZERLAND RADIOTHERAPY MARKET
9.3.5. ITALY RADIOTHERAPY MARKET
9.3.6. RUSSIA RADIOTHERAPY MARKET
9.3.7. NETHERLANDS RADIOTHERAPY MARKET
9.3.8. SPAIN RADIOTHERAPY MARKET
9.3.9. BELGIUM RADIOTHERAPY MARKET
9.3.10. TURKEY RADIOTHERAPY MARKET

9.4. APAC RADIOTHERAPY MARKET SNAPSHOT: 2016

9.4.1. JAPAN RADIOTHERAPY MARKET
9.4.2. CHINA RADIOTHERAPY MARKET
9.4.3. INDIA RADIOTHERAPY MARKET
9.4.4. SOUTH KOREA RADIOTHERAPY MARKET
9.4.5. AUSTRALIA RADIOTHERAPY MARKET
9.4.6. THAILAND RADIOTHERAPY MARKET
9.4.7. MALAYSIA RADIOTHERAPY MARKET
9.4.8. INDONESIA RADIOTHERAPY MARKET
9.4.9. SINGAPORERADIOTHERAPY MARKET
9.4.10. PHILIPPINES RADIOTHERAPY MARKET

9.5. SOUTH AMERICA RADIOTHERAPY MARKET SNAPSHOT: 2016

9.5.1. BRAZIL RADIOTHERAPY MARKET

9.6. MEA RADIOTHERAPY MARKET SNAPSHOT: 2016

9.6.1. SAUDI ARABIA RADIOTHERAPY MARKET

10. GLOBAL RADIOTHERAPY MARKET, COMPANY SHARE

10.1. COMPANY SHARE ANALYSIS: GLOBAL
10.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
10.3. COMPANY SHARE ANALYSIS: EUROPE
10.4. COMPANY SHARE ANALYSIS: ASIA PACIFIC

11. COMPANY PROFILES

11.1. VARIAN MEDICAL SYSTEMS, INC.

11.1.1. COMPANY OVERVIEW

11.1.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)

11.1.3. DRIVERS EXPLAINED

11.1.3.1. DIVERSE PRODUCT PORTFOLIO:
11.1.3.2. STRONG RESEARCH AND DEVELOPMENT CAPABILITIES:

11.1.4. WEAKNESSES EXPLAINED

11.1.4.1. DEPENDENCE ON LIMITED NUMBER OF SUPPLIERS:

11.1.5. OPPURTUNITIES EXPLAINED

11.1.5.1. VARIAN COULD EXPAND ITS POSITION WITH IMAGING COMPONENTS BUSINESS’ SPIN-OFF:
11.1.5.2. ACQUISITIONS LIKELY TO ENHANCE VARIAN’S ONCOLOGY AND IMAGING BUSINESSES:
11.1.5.3. EXPANSION IN OPERATIONS IN THE U.S.:
11.1.5.4. INCREASING INCIDENCE OF CANCER TO DRIVE GLOBAL RADIATION THERAPY EQUIPMENT MARKET:

11.1.6. THREATS EXPLAINED

11.1.6.1. INTENSE COMPETITION COULD AFFECT VARIAN’S MARKET SHARE AND RESULTS OF OPERATION:
11.1.6.2. INCREASING MEDICAL COSTS IN CANCER TREATMENT AND CARE: 259

11.1.7. REVENUE ANALYSIS

11.1.8. PRODUCT PORTFOLIO

11.1.9. RECENT DEVELOPMENTS

11.1.10. DATA BRIDGE ANALYSIS

11.2. ELEKTA AB

11.2.1. COMPANY OVERVIEW
11.2.2. REVENUE ANALYSIS
11.2.3. PRODUCT PORTFOLIO
11.2.4. RECENT DEVELOPMENTS
11.2.5. DATA BRIDGE ANALYSIS

11.3. NANOBIOTIX

11.3.1. COMPANY OVERVIEW
11.3.2. REVENUE ANALYSIS
11.3.3. PRODUCT PORTFOLIO
11.3.4. RECENT DEVELOPMENTS
11.3.5. DATA BRIDGE ANALYSIS

11.4. ACCURAY, INC.

11.4.1. COMPANY OVERVIEW
11.4.2. REVENUE ANALYSIS
11.4.3. PRODUCT PORTFOLIO
11.4.4. RECENT DEVELOPMENTS

11.5. BRAINLAB AG

11.5.1. COMPANY OVERVIEW

11.5.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)

11.5.3. DRIVERS EXPLAINED

11.5.3.1. STRONG PARTNER NETWORK:
11.5.3.2. ESTABLISHED PRESENCE IN MARKETS:

11.5.4. WEAKNESSES EXPLAINED

11.5.4.1. PRODUCT SAFETY CONCERNS:

11.5.5. OPPURTUNITIES EXPLAINED

11.5.5.1. STRATEGIC INITIATIVES:

11.5.6. THREATS EXPLAINED

11.5.6.1. RAPID TECHNOLOGICAL CHANGES:
11.5.6.2. STRINGENT GOVERNMENT REGULATIONS:

11.5.7. REVENUE ANALYSIS

11.5.8. PRODUCT PORTFOLIO

11.5.9. RECENT DEVELOPMENTS

11.6. ION BEAM APPLICATIONS SA

11.6.1. COMPANY OVERVIEW
11.6.2. REVENUE ANALYSIS
11.6.3. PRODUCT PORTFOLIO
11.6.4. RECENT DEVELOPMENTS

11.7. MEVION MEDICAL SYSTEMS, INC.
11.8. ISORAY MEDICAL, INC.
11.9. NORDION (CANADA) INC.
11.10. RAYSEARCH LABORATORIES AB

12. RELATED REPORTS

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Sopan Gedam
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.